MINNEAPOLIS--(BUSINESS WIRE)--Chromatic 3D Materials, Inc. announced today the closing of Series A funding round led by DSM Venturing. Unique 3D printable polyurethanes and foams from Chromatic 3D Materials meet the strength and durability required for finished industrial manufactured goods. With its patented technology, Chromatic 3D Materials opens the industrial use of additive manufacturing in many markets and applications for the first time. The development of this technology was supported by the National Science Foundation SBIR program.
In addition to investment, DSM and Chromatic 3D Materials will partner to introduce the technology to various markets. The first product family includes flexible polyurethane elastomers for a range of applications in the apparel, tooling, automotive, and healthcare markets.
Dr. Cora Leibig, CEO of Chromatic said: “DSM is an established material supplier in the additive manufacturing market. Together, we share a commitment to deliver the materials and technologies necessary for 3D Printing to transform manufacturing. With this investment, and with our partnership, we will accelerate our market introduction.”
About Chromatic 3D Materials
Chromatic 3D Materials has invented the next generation of 3D printing materials with the durability to meet the requirements for finished manufactured goods. Today, Chromatic offers infinite possibilities for novel product designs in a variety of markets, made possible by our customizable property range. The scope of destinations for these technologies is vast. Chromatic 3D Materials has won awards in the Minnesota Cup, the Midwest CleanTech Open, WEFest, and the New England Venture Summit. More information at www.c3dmaterials.com
About DSM – Bright Science. Brighter Living™:
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competencies in Life Sciences and Material Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com
Or find us on: